StonvexLoading…
StonvexStonvexStonvexCore line items from CIEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-01 | Annual 2024 2024-11-02 | Annual 2023 2023-10-28 | Annual 2022 2022-10-29 |
|---|---|---|---|---|
Revenue | $4.77B | $4.01B | $4.39B | $3.63B |
Operating Income | $197.53M | $166.62M | $357.55M | $222.81M |
Net Income | $123.34M | $83.96M | $254.83M | $152.90M |
EPS (Diluted) | $0.85 | $0.58 | $1.71 | $1.00 |
Total Assets | $5.86B | $5.64B | $5.60B | $5.07B |
Total Liabilities | $3.14B | $2.83B | $2.75B | $2.36B |
Cash & Equivalents | $1.09B | $934.86M | $1.01B | $994.35M |
Free Cash Flow OCF − CapEx | $665.29M | $377.89M | $62.13M | $-258.57M |
Shares Outstanding | 141.02M | 142.66M | 144.83M | 148.41M |